• About us
• Contact

Advertisement

Person › Details

Thérèse Croughs (Neovacs S.A. (Euronext Growth Paris: ALNEV))

Croughs, Thérèse (Neovacs 201509 CMO)

 

	Organisation	Neovacs S.A. (Euronext Growth Paris: ALNEV)
	Group	Neovacs (Group)
	Product	IFNalpha-Kinoid (IFNa-Kinoïd)
	Product 2	drug development

Record changed: 2018-02-20

Advertisement

More documents for Thérèse Croughs

• [1] Neovacs S.A.. (2/3/17). "Press Release: Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNa Kinoid in Lupus". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.